SG Americas Securities
AXDX

SG Americas Securities’s Accelerate Diagnostics AXDX Stock Holding History

SG Americas Securities’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,534
Closed -$89K – 3378
2021
Q3 		$89K Buy
+1,534
New +$100K ﹤0.01% 3681
2020
Q3 		– Sell
-1,690
Closed -$256K – 2719
2020
Q2 		$256K Buy
+1,690
New +$167K ﹤0.01% 2641
2019
Q3 		– Sell
-575
Closed -$132K – 2993
2019
Q2 		$132K Buy
+575
New +$112K ﹤0.01% 2659
2017
Q3 		– Sell
-1,105
Closed -$302K – 3476
2017
Q2 		$302K Buy
1,105
+516
+88% +$140K ﹤0.01% 2164
2017
Q1 		$142K Buy
589
+85
+17% +$19.4K ﹤0.01% 2702
2016
Q4 		$105K Buy
504
+59
+13% +$14K ﹤0.01% 2835
2016
Q3 		$121K Buy
+445
New +$98.5K ﹤0.01% 2912

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

SG Americas Securities's AXDX Position: Q4 2021 in Review

SG Americas Securities sold out of Accelerate Diagnostics (AXDX) in Q4 2021, closing a stake of 1,534 shares — an estimated $89K sold.

SG Americas Securities first reported a position in AXDX in Q3 2016 and held it in 7 quarters. The position peaked at $302K in Q2 2017. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2021.

  • SG Americas Securities reported no remaining Accelerate Diagnostics position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 1,534 Accelerate Diagnostics shares in Q4 2021, an estimated $89K.
  • SG Americas Securities first reported a position in Accelerate Diagnostics in Q3 2016 and held it in 7 quarters.
  • SG Americas Securities's Accelerate Diagnostics position peaked at $302K in Q2 2017.
  • 107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.